Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival

GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche

(2015) Yusuke Shiozawa et al.   NEOPLASIA

Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways

(2015) Lu Zhou et al.   NEOPLASIA

Differential Expression of Axl and Correlation with Invasion and Multidrug Resistance in Cancer Cells

(2012) Yongfu Zhao et al.   CANCER INVESTIGATION

The role of insulin-like growth factors signaling in merlin-deficient human schwannomas

(2012) Sylwia Ammoun et al.   GLIA

Emerging therapeutic targets in schwannomas and other merlin-deficient tumors

(2011) Sylwia Ammoun et al.   Nature Reviews Neurology

Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2

(2011) S. Ammoun et al.   NEURO-ONCOLOGY

Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL

(2011) A E Sayan et al.   ONCOGENE

Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival

(2011) S Ammoun et al.   ONCOGENE

Merlin/NF2 Functions Upstream of the Nuclear E3 Ubiquitin Ligase CRL4DCAF1 to Suppress Oncogenic Gene Expression

(2011) J. Cooper et al.   Science Signaling

Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus

(2010) Wei Li et al.   CELL

PI3 Kinase and PDK1 in the Regulation of the Electrogenic Intestinal Dipeptide Transport

(2010) Rexhep Rexhepaj et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Merlin in organ size control and tumorigenesis: Hippo versus EGFR?

(2010) C. Yi et al.   GENES & DEVELOPMENT

ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma

(2010) S. Ammoun et al.   NEURO-ONCOLOGY

AXL regulates mesothelioma proliferation and invasiveness

(2010) W-B Ou et al.   ONCOGENE

Involvement of Src family kinase activation in angiotensin II-induced hyperresponsiveness of rat bronchial smooth muscle

(2010) Hiroyasu Sakai et al.   PEPTIDES

Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling

(2010) Jun Du et al.   PLoS One

Ras activation contributes to the maintenance and expansion of Sca-1pos cells in a mouse model of breast cancer

(2009) Ran-Ju Kim et al.   CANCER LETTERS

PAK kinase regulates Rac GTPase and is a potential target in human schwannomas

(2009) Christine Flaiz et al.   EXPERIMENTAL NEUROLOGY

Activation of ERK, AKT and JNK signalling pathways in human schwannomasin situ

(2009) David A Hilton et al.   HISTOPATHOLOGY

Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244

(2009) Sylwia Ammoun et al.   NEUROBIOLOGY OF DISEASE

Dissecting and Targeting the Growth Factor-Dependent and Growth Factor-Independent Extracellular Signal-Regulated Kinase Pathway in Human Schwannoma

(2008) S. Ammoun et al.   CANCER RESEARCH

FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells

(2008) Weiguo Liu et al.   CARCINOGENESIS